ArticleDiabetes, obesity & metabolism2025
Subjective smell- and taste loss in diabetes-A questionnaire-based study on 47 011 individuals with diabetes and matched controls.
Article in Diabetes, obesity & metabolism, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Subjective smell- and taste loss in diabetes-A questionnaire-based study on 47 011 individuals with diabetes and matched controls.Diabetes, obesity & metabolism · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundTaste and smell disorders are more common in individuals with diabetes, particularly among those with low insulin sensitivity or central obesity. These disorders may affect glycaemic control by altering dietary habits. This study aimed to investigate self-reported taste and smell dysfunction in individuals with diabetes and explore associations with clinical and behavioural factors.
methodsWe examined self-reported taste and smell disorders in 47,011 individuals with or without diabetes using data from the Health in Central Denmark (HICD) cohort. In total, eight questions on subjective smell and taste function were included in the questionnaire.
resultsParticipants with type 2 diabetes reported significantly more qualitative and quantitative chemosensory complaints than matched controls. In contrast, no significant differences were found between individuals with Type 1 Diabetes and controls. Smoking was consistently associated with increased complaints across all groups, while HbA1c levels showed no correlation with taste or smell disorders. Obesity, particularly in women with diabetes, was linked to higher symptom reporting
conclusionsIndividuals with type 2 diabetes report more chemosensory complaints than controls. Smoking and obesity, but not HbA1c, were associated with a higher prevalence of symptoms. As subjective rating tends to underestimate true prevalence, future research should include objective testing to clarify how chemosensory disorders affect dietary behaviour and diabetes management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.